Patents by Inventor Sebastian Bonhoeffer

Sebastian Bonhoeffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140134625
    Abstract: Methods, systems, and computer readable media perform predictive modeling of gene activity. The methods may comprise obtaining the amino acid and/or nucleic acid sequence of a portion of the at least one gene from a biological sample obtained from a subject; comparing the amino acid and/or nucleic acid sequence of the portion of the at least one gene to a database of sequences for the portion of the at least one gene and for which the biological activity of the at least one gene has been evaluated; and applying a generalization of ridge regression analysis to estimate the effects of individual mutations in the at least one gene. A model is based on generalization of ridge regression (GRR) analysis to estimate the effects of individual mutations in at least one gene for the subject. At least one gene may comprise the reverse transcriptase and protease genes of an HIV vims.
    Type: Application
    Filed: January 12, 2012
    Publication date: May 15, 2014
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Mojgan Haddad, Sebastian Bonhoeffer, Trevor Hinkley
  • Publication number: 20050214752
    Abstract: This invention relates to methods for predicting replication capacity of a virus based on its genotype. It also relates to determining epistatic relationships between viral mutations, including those that affect replication capacity. It also relates to identifying targets for antiviral therapy by identifying mutations associated with altered replication capacity. The methods are useful for determining the replication capacity of an HIV based on its genotype and for identifying previously unknown interactions among viral molecules or between viral molecules and host cell molecules that are essential to viral infection and/or replication. By identifying such interactions, novel targets for antiviral therapy can be identified.
    Type: Application
    Filed: March 28, 2005
    Publication date: September 29, 2005
    Inventor: Sebastian Bonhoeffer